LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.58 | 84.90 | 6 | 663 | 0.0090 | -0.5907 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.58 | 84.90 | 1118 | 663 | 1.6852 | 1.3848 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.29 | 84.90 | 10 | 766 | 0.0130 | -0.4901 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.29 | 84.90 | 1059 | 766 | 1.3810 | 1.2140 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.29 | 84.90 | 4 | 766 | 0.0052 | -0.6180 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 16.29 | 84.90 | 1184 | 766 | 1.5440 | 1.2932 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.99 | 84.90 | 16 | 898 | 0.0178 | -0.3875 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.99 | 84.90 | 1129 | 898 | 1.2559 | 1.1384 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.99 | 84.90 | 10 | 898 | 0.0111 | -0.4665 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.99 | 84.90 | 1271 | 898 | 1.4138 | 1.2141 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 19.69 | 84.90 | 15 | 1239 | 0.0121 | -0.3612 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 19.69 | 84.90 | 1190 | 1239 | 0.9601 | 0.9791 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 19.69 | 84.90 | 17 | 1239 | 0.0137 | -0.3402 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 19.69 | 84.90 | 1365 | 1239 | 1.1013 | 1.0505 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.40 | 84.90 | 20 | 1454 | 0.0137 | -0.2972 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.40 | 84.90 | 1278 | 1454 | 0.8786 | 0.9378 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.40 | 84.90 | 18 | 1454 | 0.0124 | -0.3151 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 21.40 | 84.90 | 1433 | 1454 | 0.9851 | 0.9927 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.10 | 84.90 | 21 | 1616 | 0.0130 | -0.2801 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.10 | 84.90 | 1372 | 1616 | 0.8489 | 0.9244 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.10 | 84.90 | 26 | 1616 | 0.0161 | -0.2430 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 23.10 | 84.90 | 1537 | 1616 | 0.9510 | 0.9765 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.81 | 84.90 | 34 | 1769 | 0.0192 | -0.1885 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.81 | 84.90 | 1469 | 1769 | 0.8302 | 0.9168 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.81 | 84.90 | 36 | 1769 | 0.0203 | -0.1778 | MN20160318_Q02 | J17 |